Role of key enzyme in reducing heart disease identifiedNovember 14th, 2007 - 2:50 am ICT by admin
Plaques form when monocytes, which are cells from the blood, enter the wall of the artery and consume large amounts of the ‘bad’ cholesterol, or LDL. The monocytes then become artery-clogging foam cells.
For foam cells to get rid of their cholesterol is to by making it available to HDL, or ‘good’ cholesterol, for removal.
Cholesteryl ester hydrolase (CEH), a key enzyme present in the foam cells regulates the amount of cholesterol that can be removed by HDL.
A macrophage foam cell contained fat droplets that are surrounded by CEH showing how the enzyme associates itself with fat and releases cholesterol to be picked up by HDL.
The study led by Shobha Ghosh, Ph.D., an associate professor of internal medicine, researchers at the pulmonary division in the VCU School of Medicine examined, for the first time, how cells in the artery wall make cholesterol available for removal by HDL.
In the research transgenic mice were used which were fed a high fat and cholesterol-rich diet. Because of this, the team was able to show that by increasing the removal of cholesterol from the artery clogging foam cells, the mice with the human gene for CEH developed significantly less heart disease.
“Currently the emphasis for managing heart disease is on reducing the ‘bad’ cholesterol or LDL in the circulation. Our study demonstrates that if you can increase the removal of cholesterol from the plaques, even without changing the LDL levels, there is still a significant reduction in the plaques,” Ghosh said.
“These findings not only change the current thinking of managing heart disease but also clearly open avenues for the development of new therapies,” she said.
“By identifying CEH as a new therapeutic target, we expect that in the future patients with heart disease will have more options to aggressively treat heart disease. In addition, by determining the levels of CEH in human blood cells, we hope to be able to predict susceptibility to heart disease in the future,” she added.
The finding may also help in predicting a patient’s susceptibility to heart disease.
Ghosh said that in the study the efforts were on the examination of macrophage foam cells, which are responsible for storing large amounts of cholesterol and lead to the clogging of the arteries by forming plaques.
The study is published in the Journal of Clinical Investigation. (ANI)
- Experts wary of Lancet's study on good cholesterol - Jun 14, 2012
- Statin can prevent strokes, besides lowering lipids - Jan 05, 2012
- Targeting fatty acids in immune cells may cut atherosclerosis risk - Jul 24, 2010
- 'Bad cholesterol' also vital for health - May 06, 2011
- Routine periodic fasting good for health, heart - Apr 04, 2011
- Dark chocolate may reduce cardio risks, study shows - Apr 25, 2012
- Biomarker can nip hardening of arteries in the bud - Jan 22, 2012
- Antioxidant protein promotes clogging of arteries, says study - Jan 11, 2011
- Cholesterol levels in young adults predict future heart disease risk - Aug 03, 2010
- Clearer picture of cholesterol's link to heart disease - Feb 04, 2010
- Vitamin D supplement won't help in short term - Sep 05, 2012
- Banning trans fats from foods would prevent thousands of deaths - Apr 16, 2010
- Why low vitamin D ups diabetics' heart disease risk - Aug 22, 2009
- Clogged arteries can also cause clouded thinking - Jul 22, 2011
- Exposure to chemical may cause heart disease: Study - Sep 05, 2012
Tags: artery wall, bad cholesterol, ceh, enzyme present, foam cell, foam cells, ghosh, hdl, heart disease, internal medicine, ldl levels, monocytes, open avenues, plaques, pulmonary division, school of medicine, shobha, therapeutic target, transgenic mice, vcu school